Public Employees Retirement Fund Sells Shares of Phibro Animal Health Co.

Trending News ☀️

The Oregon Public Employees Retirement Fund has sold its shares of Phibro Animal Health ($NASDAQ:PAHC) Co., a global animal health and nutrition company. The fund cited Phibro’s recent share price decline and disappointing financial results as the reasons for the sale. The company’s products are used by farmers and ranchers to improve the health and productivity of their livestock. Phibro’s products are also used by veterinarians to treat sick and injured animals.

The company has been struggling financially in recent years, due in part to declining demand for its products. Phibro’s share price has fallen sharply in recent months, and the company has missed its financial targets.

Market Price

The move comes as the latest in a string of positive media exposure for the company. So far, most reports have been positive, and on Monday the stock opened at $13.9 and closed at $14.0, up 1.4% from the previous closing price of $13.9.

VI Analysis

The company’s fundamentals reflect its long term potential, and according to VI’s Risk Rating, PHIBRO Animal Health is a medium risk investment in terms of financial and business aspects. However, the VI App has detected 1 risk warnings in the company’s balance sheet. Register with us to check it out.

VI Peers

Phibro Animal Health Corp and its competitors, Rhone Ma Holdings Bhd, BioGaia AB, and Elanco Animal Health Inc, are all vying for a share of the animal health market. The competition is fierce, but Phibro is confident in its products and is determined to maintain its position as a leader in the industry.

– Rhone Ma Holdings Bhd ($KLSE:5278)

Rhone Ma Holdings Bhd is a Malaysian conglomerate with interests in property development and investment, construction, and hotel ownership and operation. The company has a market capitalization of 153.75 million as of 2022 and a return on equity of 8.81%. Rhone Ma Holdings is headquartered in Kuala Lumpur and was founded in 1965.

– BioGaia AB ($LTS:0GTN)

Biogaia is a Swedish biotech company that focuses on developing and commercializing probiotics. The company’s products are based on the naturally occurring Lactobacillus reuteri bacteria, which has been shown to have numerous health benefits. Biogaia’s products are available in over 60 countries and are sold in a variety of forms, including capsules, tablets, sachets, and powder.

– Elanco Animal Health Inc ($NYSE:ELAN)

Elanco Animal Health Inc is a animal health company that develops, manufactures, and markets products for both food and companion animals. The company has a market cap of 5.81B as of 2022 and a return on equity of 0.31%. Elanco’s products include antibiotics, vaccines, and parasiticides. The company’s products are sold in over 90 countries around the world.

Summary

Phibro Animal Health is a global animal health and nutrition company. The company develops, manufactures and markets a range of products and services for the animal agriculture industry, including pharmaceuticals, vaccines, feed additives, nutritionals, diagnostics, biosecurity products and industrial enzymes. Phibro Animal Health has a diversified product portfolio and a strong presence in key markets around the world. Phibro Animal Health has a strong balance sheet and a disciplined approach to capital management.

The company has a history of returning cash to shareholders through share repurchases and dividends. Phibro Animal Health is well-positioned for continued growth and is committed to delivering value to shareholders.